TNFSF10 and prostate carcinoma: PUS10 is a mediator of TNF-related apoptosis inducing ligand (TRAIL)-induced apoptosis in prostate cancer cells [283], and genomic alterations of PUS10 locus are significantly associated with lung cancer risk [284], although it is not clear whether this effects are dependent on pseudouridylase activity.